• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Startups| Digital Health | | Health IT News, Analysis, Insights - HIT Consultant

Thrive Earlier Detection Wins the BlueCross BlueShield Data Innovation Challenge

by Jasmine Pennic 12/18/2019 Leave a Comment

Blue Cross Blue Shield, BHI Launches Data Innovation Challenge

- Thrive Earlier Detection has won the BlueCross BlueShield Data Innovation Challenge for its proposal to evaluate the health-economic impact of earlier multi-cancer detection. - Thrive to analyze more than five years of Blue Cross and Blue Shield claims to detect cancer earlier and more cost-effectively- As part of winning the BlueCross BlueShield Data Innovation Challenge, Thrive will have six months of access to analyze a select dataset from BHI’s database of more than 5 billion covered
Read More

Bridge Connector Raises Additional $5M for No Code, Health Integration Platform

by Jasmine Pennic 12/11/2019 Leave a Comment

Bridge Connector Raises $20M to Solve Health IT Interoperability Challenges

- Bridge Connector raises an additional $5M reaching a total of $25M in funding for its data-driven workflow automation to solve health IT interoperability challenges. - The additional financing will support Bridge Connector’s continued scalability and its upcoming launch of Destinations, a new “no-code” integration platform as a service (iPaaS) that connects health data systems without the need for code.- The company plans to close on Series B funding in the second quarter of 2020, further
Read More

Israeli VC Firm Peregrine Ventures Closes $115M MedTech Fund

by Jasmine Pennic 12/11/2019 Leave a Comment

 - Israeli med-tech venture capital firm Peregrine Ventures raises $115M for its fourth fund focused on investing in early-stage medical technology startups. - To date, the VC firm has 10 exits totaling more than $2 billion in cumulative value and has over $200M in capital under management.Peregrine Ventures, a leading Israeli med-tech venture capital fund, today announced it has closed its fourth medtech-focused fund, Peregrine 4, raising $115 million. Their fourth medtech fund includes some of
Read More

Biotia Raises $2.4M for AI-Powered Precision Infectious Disease Detection & Diagnosis

by Fred Pennic 12/10/2019 Leave a Comment

Biotia Raises $2.4M for AI-Powered Precision Infectious Disease Detection & Diagnosis

- Pioneering pathogen detection company Biotia raises $2.4M in seed funding to expand its scientific board and further develop and implement Biotia's diagnostic testing methods, including its AI-based software platform.   - Biotia has built one of the world’s largest precision metagenomics clinical databases by working with hospitals internationally.  Biotia, an NYC-based health tech company leveraging next-generation DNA sequencing (NGS) and artificial intelligence (AI) software for precision
Read More

3 Themes Driving Today’s State of Gender Equity at Healthcare Startups & VCs

by Jasmine Pennic 12/06/2019 Leave a Comment

3 Themes Driving Today’s State of Gender Equity at Healthcare Startups & VCs

- Latest Rock Health reports reveal the in-depth survey results of 218 men, women, and non-binary respondents working at healthcare startups and VCs to understand perceive how their organizations are actively advancing gender equity. - The report reveals we are far from gender parity and the most common initiatives to promote gender equity may not be the most effective approach. - Conversations with leaders outline five core strategies for building a workplace supportive of gender equity.Despite
Read More

Rad AI Raises $4M to Automate Repetitive Tasks for Radiologists Through Machine Learning

by Fred Pennic 11/25/2019 Leave a Comment

Rad AI Raises $4M to Automate Repetitive Tasks for Radiologists Through Machine Learning

- Rad AI raises $4M in seed funding led by Gradient Ventures, Google’s AI-focused venture fund to transform radiology with the latest advances in AI to save radiologists 60+ minutes a day. - By streamlining existing workflow and automating repetitive manual tasks, Rad AI increases daily productivity while reducing radiologist burnout.  - Rad AI provides more consistent radiology reports for ordering clinicians, and higher accuracy for the patients it serves. Berkeley-based Rad AI, a
Read More

Cone Health Launches Innovation Center to Develop & Launch Ideas

by Fred Pennic 11/25/2019 Leave a Comment

Cone Health Launches Innovation Center to Develop & Launch Ideas

- Cone Health forms an innovation center named Cone Health Ventures to serve as a testing ground for new products and services focused on health and wellness. - Cone Health Ventures will serve as the innovation framework bringing together entrepreneurial insight, healthcare expertise and a human-centered approach to innovation.Cone Health, a Greensboro, NC-based integrated not-for-profit network of providers serving people in central North Carolina has announced the launch of Cone Health
Read More

Presidium Health Raises $3.5M to Expand On-Demand Care Platform

by Fred Pennic 11/21/2019 Leave a Comment

Presidium Health Raises $3.5M to Expand On-Demand Care Platform

- Presidium Health raises $3.5M to expand optimized in-home medical services based on geo-proximity to the medically complex and underserved population utilizing a home-based model of careThe company's flagship platform, STAT (Secure Text Activated Triage) is a simple user interface that provides patients with a medical alert device that allows for two-way communication, real-time transmission of vitals and personal health records to a HIPAA-compliant text platformPresidium Health, a San Diego,
Read More

GenapSys Nabs $90M to Commercialize Its Breakthrough Electronic Gene Sequencer

by Fred Pennic 11/20/2019 Leave a Comment

- GenapSys launches their first-of-its-kind electronic gene sequencer as well as the completion of a $90M series C funding round led by top biotech investor Foresite Capital. - GenapSys is the first & only to use direct electronic sequencing -- this allows for a simpler workflow, dramatically reduced costs, turnaround time and device size. - The GenapSys Sequencer is exceptionally accurate and 100x smaller and more affordable than current high-throughput sequencers and will significantly expand access to genetic health insights. GenapSys Inc. announced today that it has completed a $90 million funding round, led by Foresite Capital to commercialize the smallest and most affordable highly accurate sequencer ever developed. Now available for purchase, the device uses first-of-its-kind technology to deliver results at a fraction of the cost of legacy technologies, while still delivering highly accurate results. This latest investment round brings the company’s total funding to $166M to date. The new capital will be used to drive the commercial launch of the company’s first-generation product, grow GenapSys’ interdisciplinary team, and empower continued innovation. Accessible Sequencing Holds the Key to Innovation In 2019, 10 million people will die of cancer. And, yet, only 3 percent of cancer drugs tested in clinical trials since 2000 have been approved for patient use and not a single one offers a cure. Gene sequencing maybe the answer. By analyzing every component of our DNA, gene sequencing allows doctors and scientists to more effectively diagnose disease and develop better treatments. Beyond cancer, sequencing has the potential to supercharge everything from reproductive health to pathogen testing. But a single sequencing device typically costs up to $1M, limiting its reach and acting as a major bottleneck to advancement in healthcare. A Breakthrough in Sequencing with High Accuracy and Low Cost GenapSys is the first & only to use direct electronic sequencing -- this allows for a simpler workflow, dramatically reduced costs, turnaround time and device size miniaturized to the size of an iPad. It's up to 100x smaller and less expensive at under $10,000 than legacy sequencing technologies, while redefining the gold standard with over 99.9% accuracy. In other words, similar to the iPhone, sequencing will be taken to the size of a mobile device and made affordable to nearly any institution. For the $46B genomics market previously dominated by much more expensive device companies like Illumina, this could transform healthcare as we know it. Unlike many others on the market, GenapSys achieves gold standard accuracy while maintaining low costs and portability. An independent study conducted by The Jackson Laboratory, a leading global nonprofit biomedical research institution, found that GenapSys sequencers deliver consistent and excellent performance across a variety of biological samples. Recently at American Society of Human Genetics in Houston, The Jackson Laboratory presented the results of their study which found that the GenapSys sequencers are superior to optical detection methods in detecting single nucleotide mutations, a critical task used for cancer and inherited disease detection. Availability The GenapSys sequencer has been tested extensively across leading genomics labs across the nation. All studies thus far have indicated exceptional performance; published work is publicly available on BioRxiv. The GenapSys Sequencer is currently available for order in the U.S. with global sales beginning in early 2020. “We are entering a multi-decade era of genomics that will revolutionize many industries, including healthcare diagnostics, pharmaceutical discovery, personalized medicine, food testing, forensics, agriculture, biology and beyond - but until now, we’ve lacked the access necessary to realize this potential,” explained Dr. Hesaam Esfandyarpour, CEO and founder of GenapSys. “With our new sequencer, we can rapidly enable and scale genomics power to every researcher, physician, provider, and patient around the world.”

- GenapSys launches first-of-its-kind electronic gene sequencer as well as the completion of a $90M series C funding round led by top biotech investor Foresite Capital.  - GenapSys is the first & only to use direct electronic sequencing -- this allows for a simpler workflow, dramatically reduced costs, turnaround time and device size.- The GenapSys Sequencer is exceptionally accurate and 100x smaller and more affordable than current high-throughput sequencers and will significantly expand
Read More

Wellframe Raises $20M to Accelerate Digital Care Management Solution for Care Teams

by Fred Pennic 11/19/2019 Leave a Comment

Wellframe Raises $20M to Accelerate Digital Care Management Solution for Care Teams

- Wellframe raises $20M in Series C funding to support company growth, including hiring in its Boston office, and accelerate its leadership in the Digital Health Management market.Wellframe translates evidence-based, peer-reviewed guidelines and literature into an interactive daily checklist delivered to patients through the Wellframe mobile app.The additional funding announced today will also enable Wellframe to accelerate the next phase of its Digital Health Management solutions, Digital
Read More

  • Previous Page
  • Go to page 1
  • Interim pages omitted …
  • Go to page 123
  • Go to page 124
  • Go to page 125
  • Go to page 126
  • Go to page 127
  • Interim pages omitted …
  • Go to page 265
  • Next Page

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |